In February, Morningstar upgraded the Morningstar Analyst Ratings of four funds and one target-date series, downgraded the ratings of seven funds, and affirmed ratings on 75 funds and three target-date series.
The Chicago-based research group also assigned new ratings to eight funds and placed one fund under review.
The ratings for funds represents Morningstar’s conviction in the fund’s ability to outperform on a risk-adjusted basis over the long term. The five-tiered, qualitative Morningstar Analyst Rating scale has three positive levels, indicating Morningstar Medalists — Gold, Silver and Bronze — in addition to Neutral and Negative ratings.
As of Feb. 28, Morningstar analysts had assigned a Gold rating to 155 unique U.S. funds, a Silver rating to 337 funds, a Bronze rating to 590 funds, a Neutral rating to 690 funds, and a Negative rating to 19 funds.
Morningstar medalists currently account for approximately 6% of unique mutual funds available for sale in the United States and 61% of assets under management.
- BlackRock National Municipal (Silver from Bronze)
- Ivy Asset Strategy (Neutral from Negative)
- iShares MBS ETF (Silver from Bronze)
- JPMorgan SmartRetirement Income Target-Date Series (Gold from Silver)
- PIMCO Emerging Markets Currency (Bronze from Neutral)
- American Century Diversified Bond (Neutral from Bronze)
- AQR Large Cap Momentum Style (Neutral from Bronze)
- Domini Impact Equity (Negative from Neutral)
- Fairholme (Negative from Neutral)
- LJM Preservation and Growth (Negative from Neutral)
- Longleaf Partners Small-Cap (Bronze from Silver)
- William Blair Macro Allocation (Neutral from Bronze)
- BlackRock Total Factor (Bronze)
- Delaware Healthcare (Neutral)
- Dreyfus Global Stock (Silver)
- Fidelity Advisor Value (Neutral)
- Guggenheim S&P 500 Equal Weight ETF (Bronze)
- Loomis Sayles Growth (Silver)
- Mondrian International Equity (Bronze)
- Principal LargeCap Growth (Bronze)
- Vanguard Windsor (Under Review)